LEMBO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 7.785
EU - Europa 2.062
AS - Asia 1.089
SA - Sud America 58
AF - Africa 16
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.017
Nazione #
US - Stati Uniti d'America 7.735
IT - Italia 728
IN - India 402
SG - Singapore 393
SE - Svezia 378
UA - Ucraina 276
FI - Finlandia 254
CN - Cina 216
DE - Germania 122
GB - Regno Unito 81
RU - Federazione Russa 57
IE - Irlanda 54
AR - Argentina 45
CA - Canada 42
RO - Romania 26
ID - Indonesia 23
KR - Corea 23
NL - Olanda 20
BE - Belgio 17
HK - Hong Kong 10
BR - Brasile 9
TG - Togo 9
FR - Francia 8
AT - Austria 7
BG - Bulgaria 7
MX - Messico 7
TR - Turchia 7
JP - Giappone 6
ZA - Sudafrica 6
BA - Bosnia-Erzegovina 5
ES - Italia 5
CH - Svizzera 4
LT - Lituania 4
AU - Australia 3
UY - Uruguay 3
EU - Europa 2
IL - Israele 2
KZ - Kazakistan 2
MY - Malesia 2
NO - Norvegia 2
PL - Polonia 2
BB - Barbados 1
CL - Cile 1
GR - Grecia 1
IR - Iran 1
MK - Macedonia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.017
Città #
Fairfield 1.417
Woodbridge 735
Houston 590
Ashburn 571
Seattle 528
Wilmington 441
Cambridge 423
Ann Arbor 411
Chandler 353
San Paolo di Civitate 331
Singapore 240
Princeton 226
Plano 201
Lawrence 195
Beijing 139
Rome 131
Santa Clara 123
Boston 110
Millbury 110
San Diego 105
Jacksonville 90
Helsinki 66
Andover 63
Dearborn 63
Dublin 53
Federal 45
Des Moines 41
Boardman 36
Milan 33
Norwalk 30
Toronto 29
Falls Church 25
Moscow 24
Jakarta 23
Falkenstein 22
New York 20
Bühl 19
Hefei 15
London 15
Mannheim 15
Brussels 14
Nanjing 13
Fremont 12
Seongnam 11
Kunming 10
Buffalo 9
Indiana 9
Lomé 9
Phoenix 9
Pune 8
San Mateo 8
Guangzhou 7
Pomigliano d'Arco 7
Sofia 7
Southend 7
São Paulo 7
Vienna 7
Assisi 6
Hong Kong 6
Auburn Hills 5
Bremen 5
Centrale 5
Munich 5
Nanchang 5
Ottawa 5
Aversa 4
Dallas 4
Frankfurt am Main 4
Heidelberg 4
Istanbul 4
Jinan 4
Mexico City 4
Nuremberg 4
San Francisco 4
Seoul 4
Terzigno 4
Travnik 4
Trumbull 4
Turin 4
Bern 3
Bologna 3
Casalbordino 3
Cesate 3
Comiso 3
Eijsden 3
Eindhoven 3
Grafing 3
Las Vegas 3
Los Angeles 3
Montevideo 3
Muizenberg 3
Pittsburgh 3
Preston 3
Provo 3
Redmond 3
Seville 3
Songpa-gu 3
Springfield 3
Yellow Springs 3
Aachen 2
Totale 8.421
Nome #
Extended thromboprophylaxis with betrixaban in acutely ill medical patients 136
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial 117
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists 116
Pathophysiological Links Among Hypertension and Alzheimer's Disease 100
A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication 96
Antiinflammatory therapy with canakinumab for atherosclerotic disease 95
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction 92
Aliskiren, Enalapril, or Aliskiren and Enalapril in heart failure 90
Highlights from International Congress 89
Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity. 85
Brain MRI fiber-tracking reveals white matter alterations in hypertensive patients without damage at conventional neuroimaging 82
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial 80
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial 80
Nitroxyl (HNO) for treatment of acute heart failure 80
Telmisartan, ramipril, or both in patients at high risk for vascular events 79
Deoxycorticosterone acetate-salt hypertension activates placental growth factor in the spleen to couple sympathetic drive and immune system activation. 79
Hypertension and dementia: Epidemiological and experimental evidence revealing a detrimental relationship 79
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial 79
Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure. 79
Targeting interleukin-1β protects from aortic aneurysms induced by disrupted transforming growth factor β signaling 78
β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension 78
ABNORMAL HORMONAL AND RENAL RESPONSES TO SALINE LOAD IN HYPERTENSIVE PATIENTS WITH PARENTAL HISTORY OF CARDIOVASCULAR ACCIDENTS 77
PI3Kγ Inhibition Protects Against Diabetic Cardiomyopathy in Mice 77
PlGF, immune system and hypertension 77
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial 76
Characterization of nitric oxide release by nebivolol and its metabolites 74
Protein kinase Cθ is required for cardiomyocyte survival and cardiac remodeling 74
Angiotensin-neprilysin inhibition versus enalapril in heart failure. 74
Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. 74
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study 73
Cardiac Remodeling in Egr-1 Deficient Mice 73
Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation 73
Hemodynamic responses to atrial natriuretic factor in nephrectomized rabbits: attenuation of the circulatory consequences of acute volume expansion. 72
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure 72
The interactions of the immune system and the brain in hypertension 72
Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice 72
The multifaceted roles of PI3Kγ in hypertension, vascular biology, and inflammation 72
Role of PKC theta in cardiac homeostasis and remodelling 71
The Angiogenic Factor PlGF Mediates a Neuroimmune Interaction in the Spleen to Allow the Onset of Hypertension. 71
Hemorrhagic transformation of acute ischemic stroke is limited in hypertensive patients with cardiac hypertrophy 71
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. 70
A lesson from polycystic ovarian syndrome: untangling the role of renal sympathetic nervous system on hypertension and insulin resistance 70
Loss of EMILIN-1 Enhances Arteriolar Myogenic Tone Through TGF-β (Transforming Growth Factor-β)-Dependent Transactivation of EGFR (Epidermal Growth Factor Receptor) and Is Relevant for Hypertension in Mice and Humans 70
PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanism. 69
Acute noradrenergic activation induces insulin resistance in human skeletal muscle 69
Neuroimmune cardiovascular interfaces control atherosclerosis 69
The spleen: a hub connecting nervous and immune systems in cardiovascular and metabolic diseases 68
A novel mechanism of action for statins against diabetes-induced oxidative stress 68
Role of neuroinflammation in hypertension-induced brain amyloid pathology 67
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. 66
Ischaemic stroke following tranexamic acid in young patients carrying heterozygosity of MTHFR C677T 66
Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders. 66
Ertugliflozin and slope of chronic egfr prespecified analyses from the randomized vertis cv trial 66
Integrin signalling: The tug-of-war in heart hypertrophy 65
Blunted sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. A possible compensatory role of atrial natriuretic factor. 65
G-protein-coupled receptor kinases in hypertension 65
Effects of celiprolol on systemic and forearm circulation in hypertensive patients: a double-blind cross-over study versus metoprolol. 64
Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency 64
Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload 63
Acute hypertension induces oxidative stress in brain tissues 63
Cooperation between insulin and leptin in the modulation of vascular tone 63
Adaptative and maladaptative hypertrophic pathways: points of convergence and divergence. 61
CARDIOPULMONARY RECEPTORS AND CORONARY CIRCULATION 61
Mechanisms of Cardiac Hypertrophy 61
Chronic Type A aortic dissection: could surgical intervention be guided by molecular markers? 61
Noradrenergic vascular hyper-responsiveness in human hypertension is dependent on oxygen free radical impairment of nitric oxide activity 61
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. 61
Dietary sodium restriction impairs endothelial effect of insulin 61
Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and cardiopathic patients 60
Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy. 60
Angiotensin II directly stimulates release of atrial natriuretic factor in isolated rabbit hearts. 60
Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients 60
Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy 60
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes 60
STABLE IMPROVEMENT IN LARGE ARTERY COMPLIANCE AFTER LONG-TERM ANTIHYPERTENSIVE TREATMENT WITH ENALAPRIL 59
Increased basal nitric oxide release despite enhanced free radical production in hypertension 59
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 59
Mechanisms of soluble beta-amyloid impairment of endothelial function 59
INSULIN REDUCES REFLEX FOREARM SYMPATHETIC VASOCONSTRICTION IN HEALTHY HUMANS 59
Insulin modulation of an endothelial nitric oxide component present in the alpha-2 and beta-adrenergic responses in human forearm 58
Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature 58
Molecular interplay between mechanical and humoral signalling in cardiac hypertrophy 58
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes 57
TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice 57
Selective Rac-1 inhibition protects from diabetes-induced vascular injury 57
Resistin impairs insulin-evoked vasodilation 57
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness 57
Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure. 56
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial 56
Nitric oxide mechanisms of nebivolol 56
Advanced magnetic resonance imaging to define the microvascular injury driven by neuroinflammation in the brain of a mouse model of hypertension 55
Insulin resistance and cardiovascular risk: New insights from molecular and cellular biology 55
Prolonged duration of myocardial ischemia in patients with coronary heart disease and impaired cardiopulmonary baroreceptor sensitivity. 55
Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans. 55
Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus 55
A truncated form of teratocarcinoma-derived growth factor-1 (cripto-1) mRNA expressed in human colon carcinoma cell lines and tumors 55
SALT-INDUCED PLASTICITY IN CARDIOPULMONARY BARORECEPTOR REFLEXES IN SALT-RESISTANT HYPERTENSIVE PATIENTS 55
Cardiopulmonary exercise response in patients with left ventricular dysfunction or heart failure: a noninvasive study by gas exchange and impedance cardiography monitoring 55
Neuroimmune interactions in cardiovascular diseases 55
Telmisartan to prevent recurrent stroke and cardiovascular events. 55
Totale 6.939
Categoria #
all - tutte 35.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 108
selected - selezionate 0
volume - volumi 0
Totale 35.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.278 0 0 0 0 0 0 319 296 273 194 130 66
2020/2021924 77 94 53 48 11 41 105 78 172 147 86 12
2021/20222.227 13 118 265 66 283 60 52 247 178 171 364 410
2022/20232.004 409 637 88 176 148 156 37 91 103 77 62 20
2023/2024705 72 84 28 44 57 60 14 25 11 120 80 110
2024/2025634 54 59 118 70 132 193 8 0 0 0 0 0
Totale 11.453